Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing-- atom by atom-- both a new life-saving ...(展开全部)

Consciousness is one of science's last great unsolved mysteries. How can the salty taste and crunchy texture of potato chips, the unmistakable smell of dogs after they have been in the rain, or the exhilarating feeling of hanging on tiny fingerholds many feet above the last secure foothold on a cliff, emerge from networks of neurons and their associated synaptic and molecular p...(展开全部)

Former hacker Kevin Poulsen has, over the past decade, built a reputation as one of the top investigative reporters on the cybercrime beat. In Kingpin, he pours his unmatched access and expertise into book form for the first time, delivering a gripping cat-and-mouse narrative—and an unprecedented view into the twenty-first century’s signature form of organized crime. The word...(展开全部)

A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market―and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team―denied their share of the profits―went and did it again. In this epic saga of money and science,...(展开全部)

拜伦•奥希是卢森堡政府顾问，为该国的收购提供咨询。 蒂姆•博凯是英国的调查记者和作家，作品出现在《名利场》、《观察者》、《读者文摘》等刊物上。

Corporate takeovers can be as punishing as a heavyweight fight, and Cold Steel chronicles one of the most contentious ever. The high-stakes story reads like a gripping novel, with a rags-to-riches success story, international intrigue, astronomical volumes of money, and electrifying plot twists. With billions in cash and hundreds of thousands of jobs at stake, Arcelor owner ...(展开全部)

唐纳德·R·基尔希（Donald R. Kirsch） 博士，有35年药物研发经验，拥有24项与药物有关的专利，撰写了50篇论文，一直是著名期刊的评论员，曾在惠氏（Wyeth）、氨基氰（Cyanamid）、施贵宝（Squibb）和威尔士制药（Cambria Pharmaceuticals）等公司担任领导、研究团队主管和首席科学家，目前在哈佛进修学校教授药物研发。他目前居住在马萨诸塞州的贝德福德。 奥吉·奥加斯（Ogi Ogas） 哲学博士，专业的科学作家。《十亿个邪恶想法》（A Billion Wicked Thoughts）和《收缩》（Shrinks）的合著者，曾在《华尔街日报》（Wall Street Journal）、《波士顿环球报》（Boston Globe）、《连线》（Wired）、《魅力》（Glamour）、《种子》（Seed）、《今日心...(展开全部)

唐纳德·R·基尔希（Donald R. Kirsch） 博士，有35年药物研发经验，拥有24项与药物有关的专利，撰写了50篇论文，一直是著名期刊的评论员，曾在惠氏（Wyeth）、氨基氰（Cyanamid）、施贵宝（Squibb）和威尔士制药（Cambria Pharmaceuticals）等公司担任领导、研究团队主管和首席科学家，目前在哈佛进修学校教授药物研发。他目前居住在马萨诸塞州的贝德福德。 奥吉·奥加斯（Ogi Ogas） 哲学博士，专业的科学作家。《十亿个邪恶想法》（A Billion Wicked Thoughts）和《收缩》（Shrinks）的合著者，曾在《华尔街日报》（Wall Street Journal）、《波士顿环球报》（Boston Globe）、《连线》（Wired）、《魅力》（Glamour）、《种子》（Seed）、《今日心...(展开全部)